- Report
- May 2023
- 450 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- September 2018
- 15 Pages
Global
- Report
- November 2021
- 802 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- November 2021
- 1184 Pages
Global
From €5763EUR$6,000USD£4,961GBP
Oncolytic adenoviruses are a type of biotechnology used to treat cancer. They are genetically modified viruses that are designed to specifically target and destroy cancer cells while leaving healthy cells unharmed. Oncolytic adenoviruses are injected directly into the tumor, where they replicate and spread to other cancer cells, causing them to die. This form of therapy has been shown to be effective in treating a variety of cancers, including melanoma, breast, and lung cancer.
Oncolytic adenoviruses are a promising form of cancer treatment, as they are less toxic than traditional chemotherapy and can be used in combination with other treatments. Additionally, they can be used to target specific cancer cells, making them more effective than other treatments.
Some companies in the oncolytic adenoviruses market include Amgen, Merck, and Pfizer. Other companies, such as Oncolytics Biotech, are also researching and developing oncolytic adenoviruses for use in cancer treatment. Show Less Read more